A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

NCT01235962 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1538

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Cell Carcinoma (RCC)
Cancer

Interventions

DRUG: pazopanib
DRUG: placebo
DRUG: pazopanib
DRUG: placebo

Sponsor

Novartis Pharmaceuticals